and Maria Barna, Phd, assistant professor of developmental biology and genetics at Stanford, co-senior authors of the new study. he dogma in every textbook was that
5fc physical position in the genome makes it likely that it plays a key role in gene activity. his modification to DNA is found in very specific positions in the genome the places which regulate genes,
but the fact that wee demonstrated it can be stable in living tissue shows that it could regulate gene expression and potentially signal other events in cells.
The way these bases are ordered determines the makeup of the genome. In addition to G, C a and T, there are also small chemical modifications,
or epigenetic marks, which affect how the DNA sequence is interpreted and control how certain genes are switched on or off.
The study of these marks and how they affect gene activity is known as epigenetics. 5fc is one of these marks,
making it likely that it plays a key role in the genome. Using high-resolution mass spectrometry,
its position in the genome suggests that it has a key role in the regulation of gene expression.
as they are considered not genetically modified organisms, he says. The researchers have created an improved form of phage therapy that may become the antibiotics of the future,
including moving molecules around the interior of a cell or copying DNA into another form of genetic material, RNA.
The fifth column is implanted an bit of genetic code that sits idle until a certain drug enters the cell.
UW-Madison has opened a genome editing facility in its Biotechnology Center. e want the whole campus to utilize this technology,
This marriage between human stem cells and genome editing technology will revolutionize the way we do science.
#Pioneering gene therapy takes aim at inherited blindness Canada first human gene therapy trial for eyeshe replacement of a faulty gene with a healthy ones now underway at the Royal Alexandra Hospital to preserve
Gene therapy is not a drug, but a transfer of human genes. Gene therapy refers to the incorporation of new DNA into cells,
to replace a gene that is either missing or not functioning. This allows the cells to produce an important protein.
replacing the defective gene that in the cells. he first of six local men to undergo ocular gene therapy,
a private British biopharmaceutical company focused on the development of therapies for retinal dystrophies. e are leading the way in the development of an effective gene therapy treatment for choroideremia,
and its four relatives in the Ebolavirus genus. e expect both Marburg virus and Ebola virus to emerge again
although it can be attributed to a combination of genetics and the environment. A team of researchers from the Spanish National Cancer Research Centre (CNIO) have discovered now that telomeres
the structures that protect the chromosomes, are at the origin of pulmonary fibrosis. This is the first time that telomere damage has been identified as a cause of the disease.
a drug that affects the genetic material of cells and inhibits cell division when administered in high doses,
Our entire genome is packed this way, except for the areas, from which the information is being currently read says Vasily M. Studitsky,
information written in the genetic code, which could be imagined as the manual for its assembly where triples of nucleotides match certain amino acids,
In order to multiply, viruses have to invade a host cell and copy their genetic information. To do so, viruses encode their own replication machinery
belong to an order of RNA VIRUSES that share a common strategy for copying their genomes inside their hosts.
#Gene therapy restores hearing in deaf mice Proof-of-principle study takes a step toward precision medicine for genetic hearing loss.
Using gene therapy, researchers at Boston Children Hospital and Harvard Medical school have restored hearing in mice with a genetic form of deafness.
Their work, published online July 8 by the journal Science Translational Medicine, could pave the way for gene therapy in people with hearing loss caused by genetic mutations. ur gene therapy protocol is not yet ready for clinical trialse need to tweak it a bit moreut in the not-too-distant
The researchers tested gene therapy in two types of mutant mice. One type had the TMC1 gene completely deleted
or AAV1, together with a promoter genetic sequence that turns the gene on only in certain sensory cells of the inner ear known as hair cells.
In the recessive deafness model, gene therapy with TMC1 restored the ability of sensory hair cells to respond to soundroducing a measurable electrical currentnd also restored activity in the auditory portion of the brainstem.
but with gene therapy, they jump as high as a normal mouse, says Holt. The force of their jump was measured by a plate on the floor underneath them;
In the dominant deafness model, gene therapy with a related gene, TMC2, was successful at the cellular and brain level,
and is already in use in human gene therapy trials for blindness, heart disease, muscular dystrophy and other conditions.
Holt hopes to partner with clinicians at Boston Children Department of Otolaryngology and elsewhere to start clinical trials of TMC1 gene therapy within 5 to 10 years. urrent therapies for profound hearing loss like that caused by the recessive
Holt believes that other forms of genetic deafness may also be amenable to the same gene therapy strategy.
000 live births. can envision patients with deafness having their genome sequenced and a tailored, precision medicine treatment injected into their ears to restore hearing,
However, Holt study also showed that gene therapy with TMC2 could compensate for loss of a functional TMC1 gene,
says Holt. he implications of successful gene therapy are profound, and we are delighted to be associated with this study program,
The team developed a series of genetic parts that can be used to precisely program gene expression within the bacteria. sing these parts
or biosensors, in bacteria that are placed then in the gut, this paper stands out from the crowd by first engineering a member of the Bacteroides genus,
and if loss of PTEN could impact this central process of genome transmission to allow development and progression of cancer.
or when cells with unreplicated DNA rush into cell division prematurely to produce an abnormal number of chromosomes in a cell, a condition called aneuploidy.
Ralstonia, a genus of bacteria containing numerous soil-borne pathogen species; and Staphylococcus epidermis, a bacterium that can cause harmful biofilms on plastics like catheters in the human body.
a senior investigator at the Gladstone Institute of Cardiovascular disease and a professor of medical genetics and cellular and molecular pharmacology at UC San francisco. his technology could help us quickly screen for drugs likely to generate cardiac birth defects,
a finding that dispels previous concerns that the genetic material would quickly degrade in rain and sunlight.
Geneticists have used the technique to silence specific genes examine what functions are lost and hence learn that gene purpose.
#How to make chromosomes from DNA Researchers at the University of Tokyo have discovered a long-overlooked process important for converting a long, string-like DNA molecule into a chromosome.
This finding gives us a better understanding of the mechanism of how cells store safely genetic material, DNA.
Condensin recognizes unwound DNA segments produced by gene expression and restores them to double-stranded DNA.
This function proved to be a prerequisite for making chromosomes from DNA. DNA molecules are long,
string-like polymers storing the genetic information of life and, in a cell, are packed tightly into structures called chromosomes.
Formation of chromosomes in a dividing cell is required for faithful transmission of information in DNA to daughter cells.
The condensin complex is known to play an essential role in assembling chromosomes, but it remains unknown how condensin is involved in folding of DNA molecules.
Researchers at the University of Tokyo, including Assistant professor Takashi Sutani, Professor Katsuhiko Shirahige (Institute of Molecular and Cellular Biosciences) and Ph d student Toyonori Sakata (Graduate school of Agricultural and Life sciences), isolated from cells
and were produced by gene expression (or transcription), and that ssdna amount was increased further in condensin-deficient cells.
They also discovered that chromosome segregation defects in mutant cells that showed lowered levels of condensin function were rescued largely by transcription inhibition.
that ssdna is detrimental to assembling chromosomes, and that condensin restores unwound ssdna segments to double-stranded DNA. t was believed widely that unwound DNA segments return spontaneously to canonical double-helical DNA,
It has demonstrated also for the first time that the presence of ssdna impedes chromosome organization, providing insight into the mechanism of chromosome formation,
says Assistant professor Sutani u
#Discovery: cells unwillingly help adenoviruses Various viruses claim many lives every day and cause other nonlethal infections that can lead to serious complications.
but they are used also in sciences adenoviruses are used widely in gene therapy. Scientists found out that cells unwillingly provide lipids,
New knowledge should also help with using adenoviruses in vaccination and gene therapy e
#Scientists discover first NA ambulanceu of T researchers have discovered how severely damaged DNA is transported within a cell
because DNA contains the instructions for all our genetic information. While the repaired DNA can still replicate,
but at a great cost, said Mekhail. he cell has compromised a genome, but it stable
when our chromosomes break and are said misrepaired Durocher. his work teaches us that the location of the break within the cell nucleus has a big impact on the efficiency of repair. he implications of the research could extend to a large number of developmental
The examination of epigenomes requires mapping DNA interactions with a certain protein in the entire genome.
At one point, the study of in vivo genome-wide protein-DNA interactions and chromatin modifications required approximately 10 million cells for an individual test.
scientists have devised a new strategy to precisely modify human T cells using the genome-editing system known as CRISPR/Cas9.
and inexpensively edit genetic information in virtually any organism. T cells, which circulate in the blood, are an obvious candidate for medical applications of the technology,
But in practice, editing T cell genomes with CRISPR/Cas9 has proved surprisingly difficult, said Alexander Marson, Phd, a UCSF Sandler Fellow,
The new work was done under the auspices of the Innovative Genomics Initiative (IGI), a joint UC Berkeley-UCSF program co-directed by Berkeley Jennifer Doudna, Phd,
and allows new genetic sequences to be inserted, has generally been introduced into cells using viruses or circular bits of DNA called plasmids.
so there increasing clinical infrastructure that we could potentially piggyback on as we work out more details of genome editing,
differing by specific changes in the genetic material of the leukemia cells, but also by their response to therapies.
which occurs due to breakage and aberrant fusion of genetic material in the tumour cells, resulting in the formation of a new oncogenic protein encoded by parts of the genes TCF3 and HLF, respectively (TCF3-HLF-positive leukemia cells).
An international group of clinicians and scientists from different universities and research institutions, among them the Berlin-based Max Planck Institute for Molecular genetics (Department of Vertebrate Genomics, Hans Lehrach, group
With the aim of identifying therapeutic entry points for this incurable form of ALL THE consortium team decoded both the genome and the transcriptome of the cancer cells,
and an altered gene expression program leads to a reprogramming of leukemic cells to an early, stem-cell like, developmental stage,
but the researchers expect expenses to drop over time (as has been the case with genome sequencing).
Jewett. ur new protein-making factory holds promise to expand the genetic code in a unique and transformative way, providing exciting opportunities for synthetic biology and biomolecular engineering,
and Canadian researchers has managed to successfully sequence the full genome of a living organism using a machine the size of a smartphone called the Minion.
and get a genetic sequence right there.""The drawbacks identified so far revolve around accuracy-the data it produces is currently less accurate than the data produced by a larger machine,
and develop ways to reconstruct complete genomes off this tiny sequencer, "he said. Once proven, it's hoped that the device could be used to sequence tumour genomes,
giving the option of more personalised diagnosis and treatment to cancer patients.""It's not ready for prime time yet,
and look at their genomes we can recognize many equivalences, said molecular biologist Edward Marcotte of the University of Texas at Austin who led the new study. n fact,
#Optogenetics Meets CRISPR The CRISPR gene-editing system just got even better: a new light-activated Cas9 nuclease could offer researchers greater spatial and temporal control over the RNA-guided nuclease activity,
using its Magnet proteins to create a photoactivatable Cas9 nuclease (pacas9) for light-controlled genome editing. he existing Cas9 does not allow to modify genome of a small subset of cells in tissue, such as neurons in the brain,
We have been interested in the development of a powerful tool that enables spatial and temporal control of genome editing.
Sato said. he new study makes use of the split Cas9 architecture to enable light-activated genome editing,
Sato group now plans to expand the colors of light that can activate the pacas9 nuclease o make genome editing more flexible
hotoactivatable CRISPR-Cas9 for optogenetic genome editing, Nature Biotechnology, doi: 10.1038/nbt. 3245,2015 d
#Tasty Visuals To help those with visual impairments make out the shape and movement of objects, a company has developed a device that takes visual information
#White house unveils $215 million plan to develop patient-specific medical treatments The White house unveiled a"Precision Medicine Initiative"today a $215 million investment that will go toward building a database containing genetic information
The investment, one that part of President Obama 2016 budget proposal, will also go toward pioneering new models for patient-specific medical research research that caters to a specific patient needs based on their genetics instead of relying on a one-size-fits-all
"The Precision Medicine Initiative will leverage advances in genomics, emerging methods for managing and analyzing large data sets while protecting privacy,
or more volunteers"whose genetic information will be stored in a series of databases. About $70 million will go to the National Cancer Institute, a subsection of the NIH,
The Genetic information Nondiscrimination Act was signed into law in 2008 to prevent genetic discrimination from happening,
says Michael Eisen, a geneticist at the University of California, Berkeley.""I worry that this $200 million will ultimately come from basic research funding,
"The mosquito genome is like an unfinished puzzle""Jake and his students found a way to look in those pieces
what's referred to as the"black hole"of the genome regions full of duplicate information that are extremely hard to sequence.
and eventually exploit this male-determining factor by using transgenics, essentially changing this specific gene in mosquitoes on a deep enough cellular level that they pass it on to any offspring."
researchers detail how sequencing genetic information in sperm can show whether a man is infertile. The scientists looked at the sperm RNA,
which carries essential genetic information. But around 20 years ago, Krawetz and his research team discovered that sperm also house RNA
Since sperm RNA correspond to genes in a child genome, the researchers may be able to study these sequences to see
Finette, 58, is a professor of pediatrics, microbiology and molecular genetics at the University of Vermont College of Medicine and director of the Global Health and Humanitarian Opportunity Program.
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011